SCHEMBL6630348

SCHEMBL6630348

CC1(C)CC(C)(C)CC2(CCCCN2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3084633 0.98
SCHEMBL12733688 0.98
SCHEMBL6629718 0.93
Hydrochloric Acid SCHEMBL3079600 0.91
SCHEMBL12733696 0.90
SCHEMBL15255689 0.82
SCHEMBL746781 0.76 CHEK1 (0.36)
SCHEMBL3251801 0.76
SCHEMBL25090726 0.76 ESR1 (0.31)
SCHEMBL25231616 0.73 CHEK1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1485086-A1 AZABICYCLIC, AZATRICYCLIC AND AZASPIROCYCLIC DERIVATIVES OF AMINOCYCLOHEXANE AS NMDA, 5HT3, AND NEURONAL NICOTINIC RECEPTOR ANTAGONISTS Merz Pharma GmbH &amp; Co. KGaA (DE) 2004-12-15 EP claimed
WO-2003080046-A1 AZABICYCLIC, AZATRICYCLIC AND AZASPIROCYCLIC DERIVATIVES OF AMINOCYCLOHEXANE NMDA, 5HT3, AND NEURONAL NICOTINIC RECEPTOR ANTAGONI STS MERZ PHARMA GMBH & CO. KGAA (DE) 2003-10-02 WO claimed